MAPT and Alzheimer disease: Further, our current study observations provided protective effects of reduced VDAC1 against P‐Tau‐induced mitochondrial and synaptic toxicities in TAU (P301L) mice and provided new evidence to develop VDAC1 therapeutic strategies for AD.